<DOC>
	<DOCNO>NCT01247766</DOCNO>
	<brief_summary>The purpose study compare incidence rate infection , malignancy death among patient rheumatoid arthritis treat abatacept treated anti-rheumatic medication rheumatoid arthritis .</brief_summary>
	<brief_title>Safety Study Abatacept Treat Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Rheumatoid arthritis Receipt abatacept , biologic diseasemodifying drug , non biologic diseasemodifying antirheumatic drug Age 18 year old Below 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>